L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBN
Frais de port :
EUR 2,46
Vers Etats-Unis
Description du livre Etat : New. N° de réf. du vendeur 11627461-n
Description du livre Hardcover. Etat : new. N° de réf. du vendeur 9783034602402
Description du livre Etat : New. N° de réf. du vendeur ABLIING23Mar3113020037570
Description du livre Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. N° de réf. du vendeur ria9783034602402_lsuk
Description du livre Etat : New. N° de réf. du vendeur 11627461-n
Description du livre Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. 192 pp. Englisch. N° de réf. du vendeur 9783034602402
Description du livre Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Contemporary monograph on glutamate-based approaches to treat psychiatric drugs The approaches described in this text exploit both metabotropic and ionotropic glutamate receptors Focus on translational research, with many of the authors coming from industr. N° de réf. du vendeur 4317895
Description du livre Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. N° de réf. du vendeur 9783034602402
Description du livre Hardcover. Etat : Brand New. 1st edition. 178 pages. 10.00x6.50x0.75 inches. In Stock. N° de réf. du vendeur x-3034602405
Description du livre Etat : New. This volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. Editor(s): Skolnick, Phil. Series: Milestones in Drug Therapy. Num Pages: 178 pages, biography. BIC Classification: MMG; MMH; PSAN. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 18. Weight in Grams: 491. . 2010. Hardback. . . . . N° de réf. du vendeur V9783034602402